|
市場調査レポート
商品コード
1450090
細胞株開拓の世界市場 2024-2028Global Cell Line Development Market 2024-2028 |
||||||
カスタマイズ可能
|
細胞株開拓の世界市場 2024-2028 |
出版日: 2024年03月04日
発行: TechNavio
ページ情報: 英文 163 Pages
納期: 即納可能
![]() |
細胞株開拓市場は2023-2028年に74億1,000万米ドル、予測期間中のCAGRは14.63%で成長すると予測されます。
当レポートでは、細胞株開拓市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。モノクローナル抗体の需要増加、医薬品の特許切れ、ワクチン生産の増加などが市場を牽引しています。
市場範囲 | |
---|---|
基準年 | 2024 |
終了年 | 2028 |
予測期間 | 2024-2028 |
成長モメンタム | 加速 |
前年比2024年 | 13.59% |
CAGR | 14.63% |
増分額 | 74億1,000万米ドル |
本調査では、今後数年間の細胞株開拓市場の成長を促進する主な理由の1つとして、研究室の自動化の採用を挙げています。また、データ統合や人工知能(AI)の出現、遺伝子工学技術の進歩も市場の大きな需要につながります。
Exhibits:
The cell line development market is forecasted to grow by USD 7.41 bn during 2023-2028, accelerating at a CAGR of 14.63% during the forecast period. The report on the cell line development market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for monoclonal antibodies, patent expiration of drugs, and rise in vaccine production.
Technavio's cell line development market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 13.59% |
CAGR | 14.63% |
Incremental Value | $7.41bn |
By Product
By Source
By Geographical Landscape
This study identifies the adoption of laboratory automation as one of the prime reasons driving the cell line development market growth during the next few years. Also, emergence of data integration and artificial intelligence (AI) and advancements in genetic engineering techniques will lead to sizable demand in the market.
The report on the cell line development market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell line development market vendors that include ATCC, Boehringer Ingelheim International GmbH, Danaher Corp., DNA TwoPointO Inc., JSR Corp., Lonza Group Ltd., MabPlex International Ltd., Premas Biotech, Promega Corp., Sartorius AG, Thermo Fisher Scientific Inc., WuXi Biologics Cayman Inc., General Electric Co., and Corning Inc.. Also, the cell line development market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.